HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells (Q40421135)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells |
scientific article |
Statements
1 reference
HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells (English)
1 reference
Akira Hirata
1 reference
Fumihito Hosoi
1 reference
Miho Miyagawa
1 reference
Shu-ichi Ueda
1 reference
Seiji Naito
1 reference
Teruhiko Fujii
1 reference
Michihiko Kuwano
1 reference
Mayumi Ono
1 reference
1 May 2005
1 reference
1 reference
65
1 reference
10
1 reference
4253-4260
1 reference
Identifiers
1 reference
1 reference